Insights & Events - Hollingsworth LLP

Prescription Drug Litigation Pre-emption (part 2 of 2)

publication | November 3, 2006

LJN’s Product Liability Law & Strategy (November 2006) (Eric G. Lasker)

Daubert in Toxic Tort Litigation (part 1 of 3)

publication | October 25, 2006

Throwing Out Junk Science: The first article of this 3-part series discusses the legal standards for admissibility of medical causation expert testimony following the Michigan Supreme Court's adoption of the federal Daubert requirements of reliance and relevance. Michigan Defense Quarterly (October 2006) (Joe G. Hollingsworth and Eric G. Lasker).

Prescription Drug Litigation Pre-emption: Following the FDA Preamble (part 1 of 2)

publication | October 4, 2006

LJN’s Product Liability Law & Strategy (October 2006) (Eric G. Lasker)

How Will FDA’s New Label Rule Impact Drug Litigation?

publication | April 7, 2006

Andrew's Pharmaceutical Litigation Reporter (April 2006) (Eric G. Lasker)

Partner Eric Lasker quoted in “Agencies Move to Override State Law As Part of Federal Rulemaking Process,” in April 6, 2006 issue of BNA’s Daily Report for Executives.

publication | April 6, 2006

Federal Preemption and State Anti-“GM” Food Laws

publication | December 2, 2005

Eric G. Lasker for Washington Legal Foundation's Legal Backgrounder

Endocrine Disrupters Are Still Here

publication | November 1, 2005

IADC Product Liability Newsletter (November 2005)

Dodging Daubert: Suits against drug-makers are using bad science to invent causation.

publication | September 19, 2005

Legal Times, Food and Drug Law Supplement (September 19, 2005) (Joe G. Hollingsworth and Eric G. Lasker)

Superfund Law Preempts Contingent Fee Arrangements in Natural Resource Damages Suits

publication | July 15, 2005

Washington Legal Foundation's Legal Backgrounder (July 15, 2005) (Reprinted in the August 12, 2005, issue of Andrew's Environmental Litigation Reporter (Eric G. Lasker)

FDA Position on Federal Preemption Consistent with Law & Public Health

publication | February 25, 2005

Eric Lasker for Washington Legal Foundation's Legal Backgrounder (Reprinted in the May 19, 2005, issue of LexisNexis® Mealey's Emerging Drugs & Devices)

The Case Against Differential Diagnosis: Daubert, Medical Causation Testimony, and the Scientific Method

publication | December 1, 2004

Journal of Health Law (Winter 2004, Volume 37, No. 1) (Joe G. Hollingsworth and Eric G. Lasker)

Deciding Whether to Involve the Court in Confidential Matters

publication | September 1, 2004

LJN's Product Liability Law & Strategy, Vol. 23, No. 3 (September 2004) (Kirby T. Griffis)

The Terminix Case: Causation in Mass Tort Litigation

publication | July 24, 2004

LJN's Product Liability Law & Strategy (November/December 2004) (Kirby T. Griffis)

Daubert v. Merrell Dow Pharmaceuticals, Inc.— An Essential Tool in Natural Resource Damages Litigation

publication | December 1, 2003

ABA's Superfund and Natural Resource Damages Litigation Committee Newsletter (December 2003, Volume 1, No. 1, page 12) (Eric G. Lasker)

FDA Regulatory Action Does Not Establish Causation– FDA Borrows a Page from the Parlodel® Litigation

publication | October 7, 2003

Mealey's Emerging Drugs & Devices (Vol. 8, #19, October 7, 2003) (Eric G. Lasker)